Quest Diagnostics IncorporatedDGXNYSE
LOADING
|||
Cash Flow Performance
Modest growth trend.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$909.00M
↓ 13% below average
Average (9y)
$1.04B
Historical baseline
Range
High:$1.83B
Low:$547.00M
CAGR
+5.8%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $909.00M | +5.2% |
| 2023 | $864.00M | -34.2% |
| 2022 | $1.31B | -28.2% |
| 2021 | $1.83B | +15.3% |
| 2020 | $1.59B | +88.3% |
| 2019 | $843.00M | +3.2% |
| 2018 | $817.00M | -11.5% |
| 2017 | $923.00M | +18.9% |
| 2016 | $776.00M | +41.9% |
| 2015 | $547.00M | - |